Literature DB >> 9950877

Cadherin-5 redistribution at sites of TNF-alpha and IFN-gamma-induced permeability in mesenteric venules.

R K Wong1, A L Baldwin, R L Heimark.   

Abstract

The response of the endothelial permeability barrier in microvascular networks of the rat mesentery to perfused immune inflammatory cytokines tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) was examined. TNF-alpha (12.5 U/ml) treatment did not change albumin permeability, but in combination with IFN-gamma (20 U/ml), there was a marked increase in the number of sites of extravascular albumin in postcapillary venules. Endothelial integrity was characterized by cadherin-5 immunoreactivity, which was localized to the continuous intercellular junctions of endothelium in arterioles, capillaries, and venules. Perfusion with the combined cytokines showed that the increased albumin permeability was dose dependent and correlated with the focal disorganization of cadherin-5 at intercellular junctions of venular endothelium. No correlation was found between the increase in albumin permeability and the localization of intravascular leukocytes or extravascular mast cells. These results show that the combination of TNF-alpha and IFN-gamma induces an endothelial phenotype with focal loss of cadherin-5 intercellular adhesion, which, in part, facilitates passage of blood macromolecules and cells to the interstitium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950877     DOI: 10.1152/ajpheart.1999.276.2.H736

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  26 in total

Review 1.  Endothelial barriers: from hypothetical pores to membrane proteins.

Authors:  J A Firth
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

Review 2.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

3.  Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function.

Authors:  Victoria M Wahl-Jensen; Tatiana A Afanasieva; Jochen Seebach; Ute Ströher; Heinz Feldmann; Hans-Joachim Schnittler
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways.

Authors:  Wenchang Huang; Yiyun Liu; Lei Li; Ruyuan Zhang; Wei Liu; Jun Wu; Enqiang Mao; Yaoqing Tang
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

Review 5.  Regulation of endothelial permeability by Src kinase signaling: vascular leakage versus transcellular transport of drugs and macromolecules.

Authors:  Guochang Hu; Aaron T Place; Richard D Minshall
Journal:  Chem Biol Interact       Date:  2007-08-15       Impact factor: 5.192

6.  (-)-Deprenyl inhibits vascular hyperpermeability after hemorrhagic shock.

Authors:  Binu Tharakan; J Greg Whaley; Felicia A Hunter; W Roy Smythe; Ed W Childs
Journal:  Shock       Date:  2010-01       Impact factor: 3.454

Review 7.  Cytokine regulation of tight junctions.

Authors:  Christopher T Capaldo; Asma Nusrat
Journal:  Biochim Biophys Acta       Date:  2008-10-08

Review 8.  Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.

Authors:  M P Kim; S I Park; S Kopetz; G E Gallick
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

9.  Vascular endothelial cadherin and beta-catenin in human fetoplacental vessels of pregnancies complicated by Type 1 diabetes: associations with angiogenesis and perturbed barrier function.

Authors:  L Leach; C Gray; S Staton; M O Babawale; A Gruchy; C Foster; T M Mayhew; D K James
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

10.  VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability.

Authors:  Mingzhang Guo; Jerome W Breslin; Mack H Wu; Cara J Gottardi; Sarah Y Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2008-02-20       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.